GOP Senator Tables Bill Seeking to Triple Federal
Post# of 161
(Total Views: 96)
Posted On: 10/03/2024 5:24:31 PM
GOP Senator Tables Bill Seeking to Triple Federal THC Limit in Hemp
Last week, Senator Rand Paul reintroduced a measure that would triple THC concentrations that hemp can contain legally. The measure, called the Hemp Economic Mobilization Plan Act, is identical to a bill he introduced last Congress.
Hemp and its derivatives were legalized following the passage of the 2018 Farm Bill. Since the crop’s legalization, however, the growing industry has experienced various setbacks, with the proliferation of intoxicants pushing legislatures in different parts of the nation to control the market.
The measure, if approved, will also address different concerns the industry has expressed about federal rules. One major concern is that the 0.3% THC limit imposed on the crop is too low. If the measure is approved, that threshold would rise to 1%. Other problems addressed by the measure include issues with testing requirements.
Currently, processors of hemp have a 15-day window to test the flower and ensure the concentration of THC is within the threshold. Testing can be taxing, however, with THC being affected by different external factors only adding to the stress.
To fix this, the measure calls for final products to be tested rather than the hemp flower.
In a press release, Paul explained that while legalizing industrial hemp was a huge feat on its own, the focus was now on preventing the federal government from burdening farmers with unnecessary requirements. He added that the measure would bring transparency to government regulations and help this nascent industry reach its full potential economically.
In addition, the measure also stipulates documentation requirements for individuals transporting hemp shipments, to prevent more situations where law enforcement seizes goods in transit believed to be illegal cannabis. The documentation required would include a copy of the hemp producer’s license.
In other news, Senator Ron Wyden also introduced a bill that would establish a regulatory framework for cannabinoids derived from hemp. The bill would empower the FDA to ensure that safety standards were met to ensure no products were marketed to minors, while also allowing states to create their own regulations for CBD products.
Specifically, the legislation preserves a state’s right to set stricter rules for the products, including banning them completely. This has already been done in California, with emergency rules that prohibit the sale of products with any THC amounts taking effect last week.
The introduction of Wyden’s measure comes as congressional legislators consider other resolutions to ban cannabinoids derived from hemp, such as delta-8 THC.
These draft laws filed present intriguing possibilities for various actors, such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), that are in the business of manufacturing hemp-derived products, including pharmaceutical-grade CBD.
NOTE TO INVESTORS: The latest news and updates relating to Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) are available in the company’s newsroom at https://cnw.fm/SFWJ
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer
Last week, Senator Rand Paul reintroduced a measure that would triple THC concentrations that hemp can contain legally. The measure, called the Hemp Economic Mobilization Plan Act, is identical to a bill he introduced last Congress.
Hemp and its derivatives were legalized following the passage of the 2018 Farm Bill. Since the crop’s legalization, however, the growing industry has experienced various setbacks, with the proliferation of intoxicants pushing legislatures in different parts of the nation to control the market.
The measure, if approved, will also address different concerns the industry has expressed about federal rules. One major concern is that the 0.3% THC limit imposed on the crop is too low. If the measure is approved, that threshold would rise to 1%. Other problems addressed by the measure include issues with testing requirements.
Currently, processors of hemp have a 15-day window to test the flower and ensure the concentration of THC is within the threshold. Testing can be taxing, however, with THC being affected by different external factors only adding to the stress.
To fix this, the measure calls for final products to be tested rather than the hemp flower.
In a press release, Paul explained that while legalizing industrial hemp was a huge feat on its own, the focus was now on preventing the federal government from burdening farmers with unnecessary requirements. He added that the measure would bring transparency to government regulations and help this nascent industry reach its full potential economically.
In addition, the measure also stipulates documentation requirements for individuals transporting hemp shipments, to prevent more situations where law enforcement seizes goods in transit believed to be illegal cannabis. The documentation required would include a copy of the hemp producer’s license.
In other news, Senator Ron Wyden also introduced a bill that would establish a regulatory framework for cannabinoids derived from hemp. The bill would empower the FDA to ensure that safety standards were met to ensure no products were marketed to minors, while also allowing states to create their own regulations for CBD products.
Specifically, the legislation preserves a state’s right to set stricter rules for the products, including banning them completely. This has already been done in California, with emergency rules that prohibit the sale of products with any THC amounts taking effect last week.
The introduction of Wyden’s measure comes as congressional legislators consider other resolutions to ban cannabinoids derived from hemp, such as delta-8 THC.
These draft laws filed present intriguing possibilities for various actors, such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), that are in the business of manufacturing hemp-derived products, including pharmaceutical-grade CBD.
NOTE TO INVESTORS: The latest news and updates relating to Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) are available in the company’s newsroom at https://cnw.fm/SFWJ
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer
(0)
(0)